Cesar Pichardo results 3
· Newest (Page 1/1, per page 25)
Author: Cesar Pichardo ×Clear All Filters
Search Results
The dawn of a new era: can machine learning and large language models reshape QSP modeling?NARA Subscribed
Quantitative Systems Pharmacology (QSP) has emerged as a cornerstone of modern drug development, providing a robust framework to integrate data from preclinical and clinical studies, enhance decision-making, and optimize therapeutic strategies. By modeling biological systems and drug interactions, QSP enables predictions of outcomes, optimization of dosing regimens, and personalized medicine applications. Recent advancements i...
Minimal brain PBPK model to support the preclinical and clinical development of antibody therapeutics for CNS diseasesNARA Subscribed
There are several antibody therapeutics in preclinical and clinical development, industry-wide, for the treatment of central nervous system (CNS) disorders. Due to the limited permeability of antibodies across brain barriers, the quantitative understanding of antibody exposure in the CNS is important for the design of antibody drug characteristics and determining appropriate dosing regimens. We have developed a minimal physiol...
Previous1Next